Show simple item record

hal.structure.identifier
dc.contributor.authorLe Pen, Claude*
hal.structure.identifier
dc.contributor.authorMiadi-Fargier, Houda*
hal.structure.identifier
dc.contributor.authorDaures, JP.*
hal.structure.identifier
dc.contributor.authorMaurel, F.
HAL ID: 171784
*
hal.structure.identifier
dc.contributor.authorFautrel, B.*
hal.structure.identifier
dc.contributor.authorMaravic, M.*
dc.date.accessioned2012-03-08T15:16:02Z
dc.date.available2012-03-08T15:16:02Z
dc.date.issued2008
dc.identifier.issn1098-3015
dc.identifier.urihttps://basepub.dauphine.fr/handle/123456789/8407
dc.descriptionISPOR 11th Annual European Congress : "Moving and Improving Concepts & Evidence for Health Care Decisions", 11-2008, Athènes, Grèce
dc.language.isoenen
dc.subjectDrugs
dc.subjectPharmaceutical industry
dc.subjectHealth expenditures
dc.subjectHealth care
dc.subject.ddc334en
dc.subject.classificationjelI12en
dc.subject.classificationjelL65en
dc.titleCost-effectiveness of using etanercept as first Line in severe and highly active rheumatoid Arthritis (ra)
dc.typeArticle accepté pour publication ou publié
dc.relation.isversionofjnlnameValue in Health
dc.relation.isversionofjnlvol11
dc.relation.isversionofjnlissue6
dc.relation.isversionofjnldate2008
dc.relation.isversionofjnlpagesA541-A542
dc.relation.isversionofdoihttp://dx.doi.org/10.1016/S1098-3015(10)66787-3
dc.description.sponsorshipprivateouien
dc.relation.isversionofjnlpublisherElsevier
dc.subject.ddclabelEconomie socialeen
dc.description.ssrncandidatenon
dc.description.halcandidateoui
dc.description.readershiprecherche
dc.description.audienceInternational
dc.relation.Isversionofjnlpeerreviewedoui
dc.date.updated2017-12-22T12:38:37Z
hal.author.functionaut
hal.author.functionaut
hal.author.functionaut
hal.author.functionaut
hal.author.functionaut
hal.author.functionaut


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record